Atrial fibrillation

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

A treatment for an incurable cancer. Catheters to better diagnose and treat AFib. A surgical stapler that’s easier to use. These are just some of the Johnson & Johnson advances that are helping improve the health of people everywhere.

More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson’s Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.

Black people are far more likely to live with cardiovascular diseases than other populations in the United States. We spoke to three experts about the consequences of that disparity—and how Johnson & Johnson is actively working to help drive change and better heart health through improved education, diagnosis and treatment.

Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.

Some 33 million people worldwide have atrial fibrillation, a form of heart disease that can lead to stroke. Are you at risk? For AFib Awareness Month, take this quiz to test your AFib know-how.

The heart condition affects up to 6 million Americans, and raises the risk of stroke five-fold. For National Women’s Heart Week, one patient describes what it was like to learn she had atrial fibrillation—and the unexpected positive impact it has had on her life.

Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.